EyeCon 2026 Banner
|Articles|December 1, 2003

Intraocular implant to be tested on first patients

Bethesda, MD- Ten patients with late-stage retinitis pigmentosa (RP) will be the first humans to receive intraocular, polymer implants containing genetically modified human retinal epithelial cells that researchers hope will prevent further vision loss.


Latest CME